We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Capillary UV Imaging Detector Evaluates Biocatalytic Activity

By HospiMedica staff writers
Posted on 27 Feb 2007
A versatile format for nl scale chemistry and biochemistry separations in capillaries can be readily integrated with other in-capillary processes such as mixing and reaction, laying the foundations for a versatile and widely applicable new lab-on-capillary format. More...


Paraytec (York, UK) have released a technical application report that evaluates a novel miniature capillary ultraviolet (UV) imaging detector (ActiPix D100) on a range of nl scale enzyme assays that could be used for rapid and cost effective evaluation of biocatalytic activity and characterization of biochemical samples.

The researchers demonstrated how the lab-on-capillary approach using the ActiPix D100 allows multiplexed detection of reactions and electrophoretic separations meaning that different concentrations of an enzyme can be assayed in parallel, increasing throughput and work efficiency. Using examples of reactions catalyzed by enzymes immobilized onto beads within or on the surface of the capillary wall, the technique is readily applicable to proteomic studies (protein digestion and separation) and early stage screening in drug discovery.

The report concluded by comparing the lab-on-capillary technique with lab-on-a-chip methods. While both offer miniaturization of a wide range of procedures the lab-on-capillary technique, using the ActiPix D100, offers higher resolution separations of complex mixtures, is inherently more affordable being based upon readily available fused silica capillaries and connectors, and is much more easily integrated with other devices (pumps, detectors, power supplies).

The ActiPix D100 miniature UV imaging area detector is a miniature multiplexed capillary UV area detector. Using an active pixel area sensor to capture measurements imaging of single or multiple capillaries is readily achieved on a single sensor, unlike current commercial UV detectors. Using a capillary, as combined sample vessel, and optical element, the ActiPix D100 detector provides inherent spatial separation of sample and reference beams--the result: a unique self-referencing system in a miniature format. Allowing minute (pl to nl) volumes to be measured with high sensitivity, without sacrificing spatial resolution, the ActiPix D100 is an suitable detector for capillary liquid chromatography (LC) and capillary electrophoresis (CE) systems.

Paraytec was awarded a prize for new product innovation. The ActiPix instrument was judged the best innovative product with high growth potential developed by a company in Yorkshire, United Kingdom.


Related Links:
Paraytec

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.